Healthcare & Life Sciences
Emergo Therapeutics
United Statesemergotherapeutics.com/
Emergo Therapeutics is a Healthcare & Life Sciences startup based in the United States, most recent round Series A, 1 tracked investor.
Activeseries-a
series-a
Stage
1
Investors
About Emergo Therapeutics
Emergo Therapeutics is a company headquartered in the United States. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Emergo Therapeutics develops pharmaceutical treatments that modulate the immune system without causing immunosuppression, targeting conditions caused by cytokine dysregulation such as long COVID, influenza-like illnesses, and other respiratory viruses.
Explore Emergo Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.